Characterization of striatal cultures with the effect of QUIN and NMDA

Neuroscience Research

Volumn 49, Issue 1, 2004, Pages 29-38

  Kumar, Ujendra ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Excitotoxicity; Huntington's disease; Immunohistochemistry; NADPH diaphorase; Somatostatin; Striatum

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; QUINOLINIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SOMATOSTATIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

ANIMALS; CELL DEATH; CELLS, CULTURED; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; EXCITATORY AMINO ACID AGONISTS; IMMUNOHISTOCHEMISTRY; N-METHYLASPARTATE; NADP; NEURONS; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; QUINOLINIC ACID; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SOMATOSTATIN; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 12744265359     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.01.011     Document Type: Article

References (40)

1. Aronin N., Coper P.E., Lorenz L.J. Somatostatin is increased in the basal ganglia in Huntington's Disease. Ann. Neurol. 13:1983;519-526.
2. Augood S.J., McGowan E.K., Emson P.C. Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells. Neuroscience. 59:1994;7-12.
3. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's Disease. J. Neurosci. 11:1991;1649-1659.
4. Beal M.F., Kowall N.W., Ellison D.W., Mozurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's Disease by quinolinic acid. Nature. 321:1986;168-171.
5. Beal M.F., Kowall N.W., Swartz K.J., Ferrante R.J., Martin J.B. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse. 3(1):1989;38-47.
6. Bidmon H.J., Emde B., Kowalski T., Schmitt M., Mayer B., Kato K., Asayama K., Witte O.W., Zilles K. Nitric oxide synthase-1 containing cortical interneurons coexpress antioxidative enzymes and antiapoptotic Bcl2 following focal ischemia: evidence for direct and indirect mechanisms toward their resistance to neuropathology. J. Chem. Neuroanat. 22(3):2001;167-184.
7. Boegman R.J., Smith Y., Parent A. Quinolinic acid does not spare striatal neuropeptide Y immunoreactive neurons. Brain Res. 415:1987;178-183.
8. Boegman R.J., Parent A. Differential sensitivity of neuropeptide Y, somatostatin and NADPH-d containing neurons in rat cortex and striatum to quinolinic acid. Brain Res. 445:1988;358-362.
9. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles P-450 reductase. Nature. 351:1991;714-718.
10. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U. S. A. 87:1990;682-685.
11. Chen Q., Reiner A. Cellular distribution of the NMDA receptor NR2A/2B subunits in rat striatum. Brain Res. 743:1996;346-352.
12. Davies S.W., Robert P.J. No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid. Nature. 327:1987;326-329.
13. Dawbarn D., De Quidt M.E., Emson P.C. Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's Disease. Brain Res. 340:1985;251-260.
14. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
15. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88:1991;6368-6371.
16. East S.J., Parry-Jones A., Brotchie J.M. Ionotopic glutamate receptors and nitric oxide synthesis in the rat striatum. NeuroReport. 8:1996;71-75.
17. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P. Jr., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's Disease. Science. 230:1985;561-563.
18. Figueredo-Cardenas G., Chen Q., Reiner A. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase containing interneurons versus striatal projection neurons after intra-striatal injection of quinolinic acid in rat. Exp. Neurol. 146:1997;444-457.
19. Hirsch E.C., Graybiel A.M., Duckaerts C., Javoy-Agid F. Neuronal loss in pedunculopontine tegmental nucleus in Parkinson's Disease and in progressive supranuclear palsy. Proc. Natl. Acad. Sci. U. S. A. 84:1987;5976-5980.
20. Hope B.T., Michael G.J., Knigge K.M., Vincent S.R. Neuronal NADPH-d in a nitric oxide synthase. Proc. Natl. Acad. Sci. 8:1991;290-298.
21. Hope B.T., Vincent S.R. Histochemical characterization of neuronal NADPH-diaphorase. J. Histochem. Cytochem. 37:1989;653-661.
22. Hyman B.T., Marzlaff K., Wenniger J.J., Dawson T.M., Bredt D.S., Snyder S.H. Relative sparing of nitric oxide synthase containing neurons in the hippocampal formation in Alzheimer's Disease. Ann. Neurol. 32(6):1992;818-820.
23. Kharazia V.N., Schmidt H.W., Weinberg R. Type 1 nitric oxide synthase fully accounts for NADPH-diaphorase in rat striatum but not cortex. Neuroscience. 62:1994;983-987.
24. Kinouchi H., Epstein C.J., Miziu T., Carlson E., Chen S.F., Chan P.H. Attenuation of cerebral ischemic injury in transgenic mice over expression Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 88:1991;11158-11162.
25. Koh J.Y., Choi D.W. Cortical striatal neurons containing NADPH-d or acetylcholinetransferase are selectively resistant to injury by NMDA receptor agonist. Brain Res. 446:1988;374-378.
26. Koh J.-Y., Peters S., Choi D.W. Neurons containing NADPH-Diaphorase are selectively resistant to quinolinate toxicity. Science. 234:1986;73-76.
27. Kumar U., Asotra K., Patel S.C., Patel Y.C. Expression of NMDA receptor-1 (NR1) and Huntingtin in striatal neurons which colocalize somatostatin, neuropeptide Y and NADPH-diaphorase: a double-labeled histochemical and immunohistochemical study. Exp. Neurol. 145:1997;412-424.
28. Martin J.B., Gusella J.F. Huntington's Disease: pathogenesis and management. New Engl. J. Med. 315:1986;1267-1276.
29. MacKenjie G.M., Jenner P., Marsden C.D. The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum. Neuroscience. 67:1995;357-371.
30. Monyer H., Sprengel R., Schoepjer R. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256:1992;1217-1221.
31. Nemeroff C.B., Youngblood W.W., Prange A.J. Jr.et al. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. Science. 221:1983;972-975.
32. Norris P.J., Waldvogel H.J., Paul R.L.M., Love D.R., Emson P.C. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin mRNA in the striatum of Huntington's Disease. Neuroscience. 72:1996;1037-1047.
33. Patel S.C., Papachristou D.N., Patel Y.C. Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons. J. Neurochem. 56:1991;1286-1291.
34. Patel Y.C., Liu J.L., Warszynska A., Kent G., Papachristou D.N., Patel S.C. Differential stimulation of somatostatin but not neuropeptide Y gene expression by quinolinic acid in cultured cortical neurons. J. Neurochem. 65:1995;998-1006.
35. Qin Y., Soghomonian J.-J., Chesselet M.-F. Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the structure of adult rats. Exp. Neurol. 115:1992;200-211.
36. Reiner A., Albin R.L., Anderson K.D. Differential loss of striatal projection neurons in Huntington's Disease. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5733-5737.
37. Uemura Y., Kowall N.W., Beal M.F. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neuron in ischemic gerbil striatum. Ann. Neurol. 6:1990;20-25.
38. Vincent S.R., Johansson O. Striatal neurons containing both somatostatin-and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study. J. Comp. Neurol. 217:1983;264-270.
39. Young A.B., Greenamyre J.T., Hollingsworth Z.et al. NMDA receptor losses in putamen from patients with Huntington's Disease. Science. 241:1988;981-983.
40. Zerone M.M., Hansson O., Chen N., Wellington C.L., Leavitt B.R., Brudin P., Hayden M.R., Raymond L.A. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's Disease. Neuron. 33:2002;849-860.